title: Palliative therapy of giant basal cell carcinoma with the monoclonal anti-epidermal growth factor receptor antibody cetuximab.
authors.forename: H
authors.initials: H
authors.lastname: Müller
authors.forename: K
authors.initials: K
authors.lastname: Eisendle
authors.forename: G
authors.initials: G
authors.lastname: Gastl
authors.forename: R
authors.initials: R
authors.lastname: Höpfl
authors.forename: B
authors.initials: B
authors.lastname: Zelger
mesh_terms: D000369:Aged, 80 and over; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D002280:Basal Cell Carcinoma / Q000188:drug therapy* / Q000473:pathology; D000068818:Cetuximab; D005153:Facial Neoplasms / Q000188:drug therapy* / Q000473:pathology; D017809:Fatal Outcome; D006801:Humans; D008297:Male; D010166:Palliative Care / Q000379:methods; D012720:Severity of Illness Index
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D000068818:Cetuximab